ANTAZOLINE PHOSPHATE; NAPHAZOLINE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for antazoline phosphate; naphazoline hydrochloride and what is the scope of patent protection?
Antazoline phosphate; naphazoline hydrochloride
is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for ANTAZOLINE PHOSPHATE; NAPHAZOLINE HYDROCHLORIDE
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | ANTAZOLINE PHOSPHATE; NAPHAZOLINE HYDROCHLORIDE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ANTAZOLINE PHOSPHATE; NAPHAZOLINE HYDROCHLORIDE
US Patents and Regulatory Information for ANTAZOLINE PHOSPHATE; NAPHAZOLINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | VASOCON-A | antazoline phosphate; naphazoline hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 018746-002 | Jul 11, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |